The University of Chicago Header Logo

Connection

Paul Vezina to Motor Activity

This is a "connection" page, showing publications Paul Vezina has written about Motor Activity.
Connection Strength

5.528
  1. Locomotor conditioning by amphetamine requires cyclin-dependent kinase 5 signaling in the nucleus accumbens. Neuropharmacology. 2014 Oct; 85:243-52.
    View in: PubMed
    Score: 0.408
  2. Unpredictable saccharin reinforcement enhances locomotor responding to amphetamine. Behav Brain Res. 2012 Jan 01; 226(1):340-4.
    View in: PubMed
    Score: 0.338
  3. Casein kinase 1 enables nucleus accumbens amphetamine-induced locomotion by regulating AMPA receptor phosphorylation. J Neurochem. 2011 Jul; 118(2):237-47.
    View in: PubMed
    Score: 0.332
  4. Previous exposure to delta9-tetrahydrocannibinol enhances locomotor responding to but not self-administration of amphetamine. J Pharmacol Exp Ther. 2011 Jun; 337(3):724-33.
    View in: PubMed
    Score: 0.326
  5. Locomotor activity and cocaine-seeking behavior during acquisition and reinstatement of operant self-administration behavior in rats. Behav Brain Res. 2005 May 28; 160(2):250-9.
    View in: PubMed
    Score: 0.213
  6. Activation of group II mGlu receptors blocks the enhanced drug taking induced by previous exposure to amphetamine. Eur J Neurosci. 2005 Jan; 21(1):295-300.
    View in: PubMed
    Score: 0.212
  7. Blockade of D2 dopamine receptors in the VTA induces a long-lasting enhancement of the locomotor activating effects of amphetamine. Behav Pharmacol. 2004 Sep; 15(5-6):387-95.
    View in: PubMed
    Score: 0.208
  8. Behavioral sensitization to quinpirole is not associated with increased nucleus accumbens dopamine overflow. Neuropharmacology. 2003 Jan; 44(1):102-10.
    View in: PubMed
    Score: 0.185
  9. The mGlu2/3 receptor agonist LY379268 blocks the expression of locomotor sensitization by amphetamine. Pharmacol Biochem Behav. 2002 Sep; 73(2):333-7.
    View in: PubMed
    Score: 0.181
  10. Locomotor response to novelty predicts a rat's propensity to self-administer nicotine. Psychopharmacology (Berl). 2001 Nov; 158(2):175-80.
    View in: PubMed
    Score: 0.171
  11. Previous exposure to amphetamine enhances the subsequent locomotor response to a D1 dopamine receptor agonist when glutamate reuptake is inhibited. J Neurosci. 2001 Mar 01; 21(5):RC133.
    View in: PubMed
    Score: 0.163
  12. Induction of locomotor sensitization by amphetamine requires the activation of NMDA receptors in the rat ventral tegmental area. Psychopharmacology (Berl). 2000 Aug; 151(2-3):184-91.
    View in: PubMed
    Score: 0.156
  13. Group II, but not group I, metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. Neuropharmacology. 2000 Jul 24; 39(10):1692-9.
    View in: PubMed
    Score: 0.156
  14. The effect of previous exposure to amphetamine on drug-induced locomotion and self-administration of a low dose of the drug. Psychopharmacology (Berl). 1999 Nov; 147(2):125-34.
    View in: PubMed
    Score: 0.148
  15. Metabotropic glutamate receptors and the generation of locomotor activity: interactions with midbrain dopamine. Neurosci Biobehav Rev. 1999 Mar; 23(4):577-89.
    View in: PubMed
    Score: 0.142
  16. Blockade of glutamate reuptake in the rat nucleus accumbens increases locomotor activity. Brain Res. 1999 Feb 20; 819(1-2):165-9.
    View in: PubMed
    Score: 0.141
  17. Exposure to conditions of uncertainty promotes the pursuit of amphetamine. Neuropsychopharmacology. 2019 01; 44(2):274-280.
    View in: PubMed
    Score: 0.134
  18. Metabotropic glutamate receptors in the rat nucleus accumbens contribute to amphetamine-induced locomotion. J Pharmacol Exp Ther. 1998 Jan; 284(1):317-22.
    View in: PubMed
    Score: 0.131
  19. The metabotropic glutamate receptor antagonist (RS)-MCPG produces hyperlocomotion in amphetamine pre-exposed rats. Neuropharmacology. 1998; 37(2):189-97.
    View in: PubMed
    Score: 0.131
  20. Activation of metabotropic glutamate receptors in the rat nucleus accumbens increases locomotor activity in a dopamine-dependent manner. J Pharmacol Exp Ther. 1997 Nov; 283(2):962-8.
    View in: PubMed
    Score: 0.129
  21. Effects of naltrexone on amphetamine-induced locomotion and rearing: acute and repeated injections. Psychopharmacology (Berl). 1997 Jun; 131(3):230-8.
    View in: PubMed
    Score: 0.126
  22. Predisposition to self-administer amphetamine: the contribution of response to novelty and prior exposure to the drug. Psychopharmacology (Berl). 1997 Feb; 129(3):277-84.
    View in: PubMed
    Score: 0.123
  23. Stimuli associated with the presence or absence of amphetamine regulate cytoskeletal signaling and behavior. Eur Neuropsychopharmacol. 2016 11; 26(11):1836-1842.
    View in: PubMed
    Score: 0.120
  24. Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res. 1993 Mar 12; 605(2):332-7.
    View in: PubMed
    Score: 0.094
  25. Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects. Brain Res. 1990 May 14; 516(1):99-106.
    View in: PubMed
    Score: 0.077
  26. Transient viral-mediated overexpression of alpha-calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell leads to long-lasting functional upregulation of alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors: dopamine type-1 receptor and protein kinase A dependence. Eur J Neurosci. 2010 Apr; 31(7):1243-51.
    View in: PubMed
    Score: 0.076
  27. Transient overexpression of alpha-Ca2+/calmodulin-dependent protein kinase II in the nucleus accumbens shell enhances behavioral responding to amphetamine. J Neurosci. 2010 Jan 20; 30(3):939-49.
    View in: PubMed
    Score: 0.075
  28. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res. 1989 Oct 09; 499(1):108-20.
    View in: PubMed
    Score: 0.074
  29. Environment-specific cross-sensitization between the locomotor activating effects of morphine and amphetamine. Pharmacol Biochem Behav. 1989 Feb; 32(2):581-4.
    View in: PubMed
    Score: 0.070
  30. A role for casein kinase 1 epsilon in the locomotor stimulant response to methamphetamine. Psychopharmacology (Berl). 2009 May; 203(4):703-11.
    View in: PubMed
    Score: 0.070
  31. Enhanced nicotinic receptor function and drug abuse vulnerability. J Neurosci. 2007 Aug 15; 27(33):8771-8.
    View in: PubMed
    Score: 0.064
  32. Sensitization occurs to the locomotor effects of morphine and the specific mu opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens. Brain Res. 1987 Aug 04; 417(1):51-8.
    View in: PubMed
    Score: 0.064
  33. Conditioned locomotion and place preference elicited by tactile cues paired exclusively with morphine in an open field. Psychopharmacology (Berl). 1987; 91(3):375-80.
    View in: PubMed
    Score: 0.061
  34. Morphine conditioned place preference and locomotion: the effect of confinement during training. Psychopharmacology (Berl). 1987; 93(2):257-60.
    View in: PubMed
    Score: 0.061
  35. Blockade of group II metabotropic glutamate receptors in the nucleus accumbens produces hyperlocomotion in rats previously exposed to amphetamine. Neuropharmacology. 2006 Oct; 51(5):986-92.
    View in: PubMed
    Score: 0.059
  36. Conditioning and place-specific sensitization of increases in activity induced by morphine in the VTA. Pharmacol Biochem Behav. 1984 Jun; 20(6):925-34.
    View in: PubMed
    Score: 0.051
  37. Sensitization of midbrain dopamine neuron reactivity promotes the pursuit of amphetamine. J Neurosci. 2002 Jun 01; 22(11):4654-62.
    View in: PubMed
    Score: 0.044
  38. Previous exposure to amphetamine increases incentive to obtain the drug: long-lasting effects revealed by the progressive ratio schedule. Behav Brain Res. 2000 Jan; 107(1-2):9-19.
    View in: PubMed
    Score: 0.038
  39. Cocaine inhibits leptin-induced increase of the cocaine- and amphetamine-regulated transcript peptide in the nucleus accumbens in rats. Neuroreport. 2017 Aug 02; 28(11):701-704.
    View in: PubMed
    Score: 0.032
  40. Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the rat. Neurosci Lett. 1994 Feb 28; 168(1-2):111-4.
    View in: PubMed
    Score: 0.025
  41. Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbens. Synapse. 1994 Feb; 16(2):104-12.
    View in: PubMed
    Score: 0.025
  42. Cortico-subcortical interactions in behavioral sensitization: differential effects of daily nicotine and morphine. Ann N Y Acad Sci. 1992 Jun 28; 654:101-16.
    View in: PubMed
    Score: 0.022
  43. a-1 Adrenergic receptors are localized on presynaptic elements in the nucleus accumbens and regulate mesolimbic dopamine transmission. Neuropsychopharmacology. 2012 Aug; 37(9):2161-72.
    View in: PubMed
    Score: 0.022
  44. Nicotine and morphine differentially activate brain dopamine in prefrontocortical and subcortical terminal fields: effects of acute and repeated injections. J Pharmacol Exp Ther. 1992 May; 261(2):484-90.
    View in: PubMed
    Score: 0.022
  45. Blockade of group II, but not group I, mGluRs in the rat nucleus accumbens inhibits the expression of conditioned hyperactivity in an amphetamine-associated environment. Behav Brain Res. 2008 Aug 05; 191(1):62-6.
    View in: PubMed
    Score: 0.017
  46. Hyperthermia induced by morphine administration to the VTA of the rat brain: an effect dissociable from morphine-induced reward and hyperactivity. Life Sci. 1985 Mar 18; 36(11):1095-105.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.